Elliott Management’s Pfizer PFE Stock Holding History

Elliott Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,137,458	Closed	-$116M	–	96
2016 Q1	$116M	Buy	+4,137,458	New	+$118M	1.22%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Elliott Management's PFE Position: Q2 2016 in Review

Elliott Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 4,137,458 shares — an estimated $116M sold.

Elliott Management first reported a position in PFE in Q1 2016 and held it in 1 quarter. The position peaked at $116M in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Elliott Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Elliott Management sold 4,137,458 Pfizer shares in Q2 2016, an estimated $116M.
Elliott Management first reported a position in Pfizer in Q1 2016 and held it in 1 quarter.
Elliott Management's Pfizer position peaked at $116M in Q1 2016.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Elliott Management's 13F filing for Q2 2016, filed 15 Aug 2016.